Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx (MDXG) Income from Continuing Operations (2016 - 2025)

Mimedx (MDXG) has disclosed Income from Continuing Operations for 15 consecutive years, with 15191000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 104.24% to 15191000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 48580000.0 through Dec 2025, up 15.67% year-over-year, with the annual reading at 48578000.0 for FY2025, 15.67% up from the prior year.
  • Income from Continuing Operations hit 15191000.0 in Q4 2025 for Mimedx, down from 16748000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 51288000.0 in Q4 2023 to a low of 10868000.0 in Q2 2022.
  • Historically, Income from Continuing Operations has averaged 6288150.0 across 5 years, with a median of 7658000.0 in 2024.
  • Biggest YoY gain for Income from Continuing Operations was 4839.7% in 2022; the steepest drop was 510.91% in 2022.
  • Year by year, Income from Continuing Operations stood at 199000.0 in 2021, then surged by 4839.7% to 9830000.0 in 2022, then skyrocketed by 421.75% to 51288000.0 in 2023, then tumbled by 85.5% to 7438000.0 in 2024, then skyrocketed by 104.24% to 15191000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for MDXG at 15191000.0 in Q4 2025, 16748000.0 in Q3 2025, and 9618000.0 in Q2 2025.